Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

ClinicalTrials.gov ID: NCT00806754

Public ClinicalTrials.gov record NCT00806754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

* The primary objective of this study is to evaluate the efficacy of the concomitant administration of ciclesonide nasal spray and azelastine nasal spray versus ciclesonide nasal spray alone in patients (18 years or older) with perennial allergic rhinitis (PAR) not adequately controlled on an intranasal corticosteroid or antihistamine monotherapy * The secondary objective is to investigate the safety of the concomitant administration of ciclesonide nasal spray and azelastine nasal spray

Study identification

NCT ID
NCT00806754
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
340 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
May 2007 (Actual)
Completion
Aug 2007 (Actual)
Last update posted
Nov 23, 2016

2006 – 2007

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Altana/Nycomed Encinitas California 92024 —
Altana/Nycomed Los Angeles California 90025 —
Altana/Nycomed Mission Viejo California 92691 —
Altana/Nycomed San Diego California 92123 —
Altana/Nycomed San Jose California 95117 —
Altana/Nycomed Colorado Springs Colorado 80907 —
Altana/Nycomed Denver Colorado 80206 —
Altana/Nycomed Lakewood Colorado 80401 —
Altana/Nycomed Gainesville Georgia 30501 —
Altana/Nycomed Savannah Georgia 31406 —
Altana/Nycomed Stockbridge Georgia 30281 —
Altana/Nycomed Overland Park Kansas 66210 —
Altana/Nycomed Metairie Louisiana 70006 —
Altana/Nycomed Shreveport Louisiana 71105 —
Altana/Nycomed Bethesda Maryland 20814 —
Altana/Nycomed North Dartmouth Massachusetts 02747 —
Altana/Nycomed Novi Michigan 48375 —
Altana/Nycomed Rolla Missouri 65401 —
Altana/Nycomed Papillion Nebraska 68046 —
Altana/Nycomed Skillman New Jersey 08558 —
Altana/Nycomed Raleigh North Carolina 27612 —
Altana/Nycomed Cincinnati Ohio 45231 —
Altana/Nycomed Sylvania Ohio 43560 —
Altana/Nycomed Ashland Oregon 97520 —
Altana/Nycomed Medford Oregon 97504 —
Altana/Nycomed Portland Oregon 97213 —
Altana/Nycomed Pittsburgh Pennsylvania 15241 —
Altana/Nycomed Upland Pennsylvania 19013 —
Altana/Nycomed Charleston South Carolina 29414 —
Altana/Nycomed Dallas Texas 75231 —
Altana/Nycomed San Antonio Texas 78229 —
Altana/Nycomed South Burlington Vermont 05403 —
Altana/Nycomed Newport News Virginia 23606 —
Altana/Nycomed Richmond Virginia 23226 —
Altana/Nycomed Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00806754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 23, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00806754 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →